Safety and Feasibility of CIK Cell Therapy in HCC After Tumor Resection

NCT07709299 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

6

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hepatocellular Carcinoma (HCC)

Interventions

BIOLOGICAL: Autologous Cytokine-Induced Killer (CIK) Cells

Sponsor

Royan Institute

Collaborators

[object Object]
[object Object]